Cite
HARVARD Citation
Abed, A. et al. (n.d.). LBA14Genomic HLA heterozygosity as a predictive marker for survival in lung cancer patients post immunotherapy. Annals of oncology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Abed, A. et al. (n.d.). LBA14Genomic HLA heterozygosity as a predictive marker for survival in lung cancer patients post immunotherapy. Annals of oncology. p. . [Online].